Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO).
Journal
Nature neuroscience
ISSN: 1546-1726
Titre abrégé: Nat Neurosci
Pays: United States
ID NLM: 9809671
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
29
10
2019
accepted:
14
01
2022
pubmed:
2
3
2022
medline:
27
4
2022
entrez:
1
3
2022
Statut:
ppublish
Résumé
Benzodiazepines are widely administered drugs to treat anxiety and insomnia. In addition to tolerance development and abuse liability, their chronic use may cause cognitive impairment and increase the risk for dementia. However, the mechanism by which benzodiazepines might contribute to persistent cognitive decline remains unknown. Here we report that diazepam, a widely prescribed benzodiazepine, impairs the structural plasticity of dendritic spines, causing cognitive impairment in mice. Diazepam induces these deficits via the mitochondrial 18 kDa translocator protein (TSPO), rather than classical γ-aminobutyric acid type A receptors, which alters microglial morphology, and phagocytosis of synaptic material. Collectively, our findings demonstrate a mechanism by which TSPO ligands alter synaptic plasticity and, as a consequence, cause cognitive impairment.
Identifiants
pubmed: 35228700
doi: 10.1038/s41593-022-01013-9
pii: 10.1038/s41593-022-01013-9
doi:
Substances chimiques
Bzrp protein, mouse
0
Mitochondrial Proteins
0
Receptors, GABA
0
Benzodiazepines
12794-10-4
Diazepam
Q3JTX2Q7TU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
317-329Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.
Références
Rudolph, U. & Knoflach, F. Beyond classical benzodiazepines: novel therapeutic potential of GABA
pmcid: 3375401
doi: 10.1038/nrd3502
Rupprecht, R. et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov. 9, 971–988 (2010).
doi: 10.1038/nrd3295
Papadopoulos, V. et al. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402–409 (2006).
pubmed: 16822554
doi: 10.1016/j.tips.2006.06.005
Liu, G.-J. et al. Functional gains in energy and cell metabolism after TSPO gene insertion. Cell Cycle 16, 436–447 (2017).
pubmed: 28103132
pmcid: 5351937
doi: 10.1080/15384101.2017.1281477
Gut, P., Zweckstetter, M. & Banati, R. B. Lost in translocation: the functions of the 18-kD translocator protein. Trends Endocrinol. Metab. 26, 349–356 (2015).
pubmed: 26026242
pmcid: 5654500
doi: 10.1016/j.tem.2015.04.001
Barker, M. J., Greenwood, K. M., Jackson, M. & Crowe, S. F. Cognitive effects of long-term benzodiazepine use. CNS Drugs 18, 37–48 (2004).
pubmed: 14731058
doi: 10.2165/00023210-200418010-00004
Arolfo, M. P. & Brioni, J. D. Diazepam impairs place learning in the Morris water maze. Behav. Neural Biol. 55, 131–136 (1991).
pubmed: 1996944
doi: 10.1016/0163-1047(91)80133-Y
Gallacher, J. et al. Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS). J. Epidemiol. Community Health 66, 869–873 (2012).
pubmed: 22034632
doi: 10.1136/jech-2011-200314
de Gage, S. B. et al. Benzodiazepine use and risk of Alzheimer’s disease: case–control study. BMJ 349, g5205 (2014).
doi: 10.1136/bmj.g5205
Penninkilampi, R. & Eslick, G. D. A systematic review and meta-analysis of the risk of dementia associated with benzodiazepine use, after controlling for protopathic bias. CNS Drugs 32, 485–497 (2018).
pubmed: 29926372
doi: 10.1007/s40263-018-0535-3
Gray, S. L. et al. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ 352, i90 (2016).
pubmed: 26837813
pmcid: 4737849
doi: 10.1136/bmj.i90
Biétry, F. A., Pfeil, A. M., Reich, O., Schwenkglenks, M. & Meier, C. R. Benzodiazepine use and risk of developing Alzheimer’s disease: a case–control study based on Swiss claims data. CNS Drugs 31, 245–251 (2017).
pubmed: 28078633
doi: 10.1007/s40263-016-0404-x
Kasai, H., Fukuda, M., Watanabe, S., Hayashi-Takagi, A. & Noguchi, J. Structural dynamics of dendritic spines in memory and cognition. Trends Neurosci. 33, 121–129 (2010).
pubmed: 20138375
doi: 10.1016/j.tins.2010.01.001
Zou, C. et al. Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer’s disease. Acta Neuropathol. 131, 235–246 (2016).
pubmed: 26724934
pmcid: 4713725
doi: 10.1007/s00401-015-1527-8
Zuo, Y., Lin, A., Chang, P. & Gan, W.-B. Development of long-term dendritic spine stability in diverse regions of cerebral cortex. Neuron 46, 181–189 (2005).
pubmed: 15848798
doi: 10.1016/j.neuron.2005.04.001
Grutzendler, J., Kasthuri, N. & Gan, W.-B. Long-term dendritic spine stability in the adult cortex. Nature 420, 812–816 (2002).
pubmed: 12490949
doi: 10.1038/nature01276
Feng, G. et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28, 41–51 (2000).
pubmed: 11086982
doi: 10.1016/S0896-6273(00)00084-2
Rudolph, U. et al. Benzodiazepine actions mediated by specific γ-aminobutyric acid
pubmed: 10548105
doi: 10.1038/44579
Richter, L. et al. Diazepam-bound GABA
pmcid: 3368153
doi: 10.1038/nchembio.917
Ralvenius, W. T., Benke, D., Acuna, M. A., Rudolph, U. & Zeilhofer, H. U. Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABA
pubmed: 25865415
pmcid: 4829939
doi: 10.1038/ncomms7803
Sohal, V. S., Zhang, F., Yizhar, O. & Deisseroth, K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459, 698–702 (2009).
pubmed: 19396159
pmcid: 3969859
doi: 10.1038/nature07991
Hu, H., Gan, J. & Jonas, P. Fast-spiking, parvalbumin
pubmed: 25082707
doi: 10.1126/science.1255263
Pritchett, D. B. & Seeburg, P. H. γ‐Aminobutyric acid
pubmed: 2157817
doi: 10.1111/j.1471-4159.1990.tb01237.x
Romeo, E. et al. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J. Pharmacol. Exp. Ther. 262, 971–978 (1992).
pubmed: 1326631
Löw, K. et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290, 131–134 (2000).
pubmed: 11021797
doi: 10.1126/science.290.5489.131
Crestani, F. et al. Trace fear conditioning involves hippocampal α
pubmed: 12084936
pmcid: 124409
doi: 10.1073/pnas.142288699
Banati, R. B. et al. Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. Nat. Commun. 5, 5452 (2014).
pubmed: 25406832
doi: 10.1038/ncomms6452
Brendel, M. et al. Glial activation and glucose metabolism in a transgenic amyloid mouse model: a triple-tracer PET study. J. Nucl. Med. 57, 954–960 (2016).
pubmed: 26912428
doi: 10.2967/jnumed.115.167858
Kreisl, W. C. et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease. Brain 136, 2228–2238 (2013).
pubmed: 23775979
pmcid: 3692038
doi: 10.1093/brain/awt145
Cagnin, A. et al. In-vivo measurement of activated microglia in dementia. Lancet 358, 461–467 (2001).
pubmed: 11513911
doi: 10.1016/S0140-6736(01)05625-2
Wolf, L. et al. Enhancing neurosteroid synthesis—relationship to the pharmacology of translocator protein (18 kDa)(TSPO) ligands and benzodiazepines. Pharmacopsychiatry 48, 72–77 (2015).
pubmed: 25654303
doi: 10.1055/s-0035-1558003
Salter, M. W. & Stevens, B. Microglia emerge as central players in brain disease. Nat. Med. 23, 1018–1027 (2017).
pubmed: 28886007
doi: 10.1038/nm.4397
Wake, H., Moorhouse, A. J., Miyamoto, A. & Nabekura, J. Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci. 36, 209–217 (2013).
pubmed: 23260014
doi: 10.1016/j.tins.2012.11.007
Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712–716 (2016).
pubmed: 27033548
pmcid: 5094372
doi: 10.1126/science.aad8373
Chung, W.-S., Welsh, C. A., Barres, B. A. & Stevens, B. Do glia drive synaptic and cognitive impairment in disease? Nat. Neurosci. 18, 1539–1545 (2015).
pubmed: 26505565
pmcid: 4739631
doi: 10.1038/nn.4142
Elmore, M. R. et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82, 380–397 (2014).
pubmed: 24742461
pmcid: 4161285
doi: 10.1016/j.neuron.2014.02.040
Paolicelli, R. C. et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456–1458 (2011).
pubmed: 21778362
doi: 10.1126/science.1202529
Neniskyte, U. & Gross, C. T. Errant gardeners: glial-cell-dependent synaptic pruning and neurodevelopmental disorders. Nat. Rev. Neurosci. 18, 658–670 (2017).
pubmed: 28931944
doi: 10.1038/nrn.2017.110
Dejanovic, B. et al. Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies. Neuron 100, 1322–1336 (2018).
pubmed: 30392797
doi: 10.1016/j.neuron.2018.10.014
Liu, Y. U. et al. Neuronal network activity controls microglial process surveillance in awake mice via norepinephrine signaling. Nat. Neurosci. 22, 1771–1781 (2019).
pubmed: 31636449
pmcid: 6858573
doi: 10.1038/s41593-019-0511-3
Umpierre, A. D. & Wu, L. J. How microglia sense and regulate neuronal activity. Glia 69, 1637–1653 (2021).
pubmed: 33369790
doi: 10.1002/glia.23961
Zhang, Y., Zhou, X.-h, Meranus, D. H., Wang, L. & Kukull, W. A. Benzodiazepine use and cognitive decline in elderly with normal cognition. Alzheimer Dis. Assoc. Disord. 30, 113–117 (2016).
pmcid: 4670597
doi: 10.1097/WAD.0000000000000099
Pariente, A., de Gage, S. B., Moore, N. & Bégaud, B. The benzodiazepine–dementia disorders link: current state of knowledge. CNS Drugs 30, 1–7 (2016).
pubmed: 26715389
doi: 10.1007/s40263-015-0305-4
Filipello, F. et al. The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immunity 48, 979–991 (2018).
pubmed: 29752066
doi: 10.1016/j.immuni.2018.04.016
Paolicelli, R. C. et al. TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss. Neuron 95, 297–308 (2017).
pubmed: 28669544
pmcid: 5519492
doi: 10.1016/j.neuron.2017.05.037
Lechin, F. et al. Peripheral blood immunological parameters in long-term benzodiazepine users. Clin. Neuropharmacol. 17, 63–72 (1994).
Covelli, V. et al. Effects of benzodiazepines on the immune system. Acta Neurologica 13, 418–423 (1991).
pubmed: 1776530
Colasanti, A. et al. Bipolar disorder is associated with the rs6971 polymorphism in the gene encoding 18 kDa translocator protein (TSPO). Psychoneuroendocrinology 38, 2826–2829 (2013).
pubmed: 23942012
pmcid: 3820042
doi: 10.1016/j.psyneuen.2013.07.007
Jung, S. et al. Analysis of fractalkine receptor CX
pubmed: 10805752
pmcid: 85780
doi: 10.1128/MCB.20.11.4106-4114.2000
Fuhrmann, M., Mitteregger, G., Kretzschmar, H. & Herms, J. Dendritic pathology in prion disease starts at the synaptic spine. J. Neurosci. 27, 6224–6233 (2007).
pubmed: 17553995
pmcid: 6672160
doi: 10.1523/JNEUROSCI.5062-06.2007
Mrsic-Flogel, T. D. et al. Homeostatic regulation of eye-specific responses in visual cortex during ocular dominance plasticity. Neuron 54, 961–972 (2007).
pubmed: 17582335
doi: 10.1016/j.neuron.2007.05.028
Deussing, M. et al. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [
pubmed: 28988133
doi: 10.1016/j.neuroimage.2017.10.006
Kleinberger, G. et al. The FTD‐like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism. EMBO J. 36, 1837–1853 (2017).
pubmed: 28559417
pmcid: 5494459
doi: 10.15252/embj.201796516
Leger, M. et al. Object recognition test in mice. Nat. Protoc. 8, 2531–2537 (2013).
doi: 10.1038/nprot.2013.155